New Biomarkers for Prostate Cancer Detection Show Promising Results

Strategic Insights -

A recent study conducted at the Methodist Hospital in Ghana has shed light on the potential of serum ferritin and hepcidin as complementary biomarkers for prostate disease. The research, published in the Health Science Reports journal, used a hospital-based case-control study involving 90 participants to explore the correlation between serum PSA levels and these new biomarkers. The findings suggest that high levels of serum ferritin and hepcidin could play a valuable role in complementing the non-invasive total PSA test to improve diagnostic accuracy.

Key Takeaways:

  • The study found a significant correlation between high levels of serum ferritin and hepcidin and increased serum total PSA levels.
  • The results suggest that serum ferritin and hepcidin could serve as complementary biomarkers for prostate disease, improving diagnostic accuracy.
  • The study involved 90 participants, including patients with prostate cancer and healthy controls, who were recruited from the Methodist Hospital in Ghana.
  • The research used a hospital-based case-control study design, with venous blood samples collected for complete blood count, PSA, ferritin, and hepcidin measurements.
  • The data were analyzed using SPSS version 27, and the results showed a direct correlation between serum ferritin and hepcidin levels and increased serum total PSA levels.
  • The study was conducted by a team of researchers from the Department of Haematology, School of Allied Health Sciences, University for Development Studies Tamale Ghana, led by Samuel Kwasi Appiah.
  • The research has the potential to improve prostate cancer diagnosis and treatment by providing a more accurate and non-invasive diagnostic tool.

Statistics:

  • 90 participants were involved in the study, including patients with prostate cancer and healthy controls.
  • The study found a significant correlation between high levels of serum ferritin (p < 0.01) and hepcidin (p < 0.05) and increased serum total PSA levels.
  • The results suggest that serum ferritin and hepcidin could serve as complementary biomarkers for prostate disease, improving diagnostic accuracy by up to 20%.

Sources:

  • Appiah, S. K., et al. (2025). Diagnostic Significance of Serum Ferritin and Hepcidin as Complementary Biomarkers for Prostate Disease: A Prospective Case-Control Study in a Mission Hospital, Ghana. Health Science Reports, 8(4), n/a-n/a. (Health Science Reports - https://onlinelibrary.wiley.com/journal/23988835)
  • "Study Findings from Department of Haematology Advance Knowledge in Prostate Cancer (Diagnostic Significance of Serum Ferritin and Hepcidin as Complementary Biomarkers for Prostate Disease: A Prospective Case-Control Study in a Mission Hospital, ...)." Health & Medicine Week. May 16, 2025; p 7339.